علاج الرجفان الأذيني المشخَّص لأول مرة في المرضى المستقرين ديناميكيًا

References

DOI: 10.1093/eurheartj/ehae176

• AF that has not been diagnosed before, regardless of symptom status, temporal pattern, or duration.
• Rate control therapy is recommended in patients with AF, as initial therapy in the acute setting, an adjunct to rhythm control therapies, or as a sole treatment strategy to control heart rate and reduce symptoms.
• Beta-blockers and/or digoxin are recommended in patients with AF and LVEF ≤40% to control heart rate and reduce symptoms.
• Beta-blockers, diltiazem, verapamil, or digoxin are recommended as first-choice drugs in patients with AF and LVEF >40% to control heart rate and reduce symptoms.
• Lenient rate control with a resting heart rate of <110 b.p.m. should be considered as the initial target for patients with AF, with stricter control reserved for those with continuing AF-related symptoms.